Stock Market Shock: 4 Giants Under Investigation - Is Your Investment at Risk?

NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against four major companies, sending shockwaves throughout the stock market. The four companies under investigation include MaxLinear, Inc. (NASDAQ:MXL), Customers Bancorp, Inc. (NYSE:CUBI), Globus Medical, Inc. (NYSE:GMED), and Metagenomi, Inc. (NASDAQ:MGX).

The investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. The law firm encourages investors to contact them to further discuss their options and potential next steps.

Let's dive into the specific details of each company under investigation. First up is MaxLinear, Inc. Following the close of the financial markets on July 24, 2024, MaxLinear publicly disclosed its earnings results for the second fiscal quarter of 2024. The company reported net revenue amounting to $92 million for the quarter, representing a significant decrease of 50% compared to the corresponding period in the prior year. This substantial decline in revenue has raised several eyebrows, and investors are now questioning the company's business practices.

According to MaxLinear, several contributing factors led to this decline in revenue, notably attributing it, at least in part, to the prolonged depletion of excess customer inventory, which has resulted in a consequent weakening of demand for its products. However, this reasoning does not seem to have calmed investors, as the stock was trading down 29% during early morning trading on July 25, 2024. This sharp decline in stock price has left investors scrambling to understand what's happening and what it means for their investments.

The second company under investigation is Customers Bancorp, Inc. On April 12, 2024, Customers Bancorp disclosed in a filing with the U.S. Securities and Exchange Commission. While the details of the filing are not explicitly stated in the notification, the law firm is likely looking into whether the company engaged in any unlawful business practices that could have an adverse impact on investors.

The final two companies under investigation are Globus Medical, Inc. and Metagenomi, Inc. While specific details regarding these investigations are not yet available, it's clear that Bragar Eagel & Squire, P.C. is taking a close look at the business practices of each company and their potential impact on investors.

As the investigations continue, it's essential for investors to understand their options and potential next steps. By reaching out to Bragar Eagel & Squire, P.C., investors can discuss their concerns and determine if they have a case. It's crucial for investors to stay informed and up-to-date on any developments in these investigations to make informed decisions about their investments.

For more information on each case, please visit the following links: MaxLinear, Inc., Customers Bancorp, Inc., Globus Medical, Inc., and Metagenomi, Inc.